Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients

被引：0
|
作者：
Naomi Iwasa-Inoue
Hiroyuki Nomura
Fumio Kataoka
Tatsuyuki Chiyoda
Tomoko Yoshihama
Yoshiko Nanki
Kensuke Sakai
Yusuke Kobayashi
Wataru Yamagami
Tohru Morisada
Akira Hirasawa
Daisuke Aoki
机构：
[1] Keio University School of Medicine,Department of Obstetrics and Gynecology
[2] National Hospital Organization Saitama Hospital,Department of Obstetrics and Gynecology
[3] Fujita Health University,Department of Obstetrics and Gynecology, School of Medicine
[4] International University of Health and Welfare School of Medicine,Department of Obstetrics and Gynecology
[5] Okayama University,Department of Clinical Genomic Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
来源：
International Journal of Clinical Oncology | 2022年 / 27卷
关键词：
Ovarian cancer; Neoadjuvant chemotherapy; Dose-dense TC; Bevacizumab; Feasibility;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：441 / 447
页数：6
相关论文
共 50 条
  • [1] Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients
    Iwasa-Inoue, Naomi
    Nomura, Hiroyuki
    Kataoka, Fumio
    Chiyoda, Tatsuyuki
    Yoshihama, Tomoko
    Nanki, Yoshiko
    Sakai, Kensuke
    Kobayashi, Yusuke
    Yamagami, Wataru
    Morisada, Tohru
    Hirasawa, Akira
    Aoki, Daisuke
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (02) : 441 - 447
  • [2] PROSPECTIVE FEASIBILITY STUDY OF NEOADJUVANT DOSE-DENSE PACLITAXEL PLUS CARBOPLATIN WITH BEVACIZUMAB THERAPY FOR ADVANCED OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER PATIENTS
    Nomura, H.
    Iwasa, N.
    Kataoka, F.
    Chiyoda, T.
    Yamagami, W.
    Fujii, T.
    Aoki, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A150 - A150
  • [3] Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas
    T. Ebata
    M. Yunokawa
    S. Bun
    A. Shimomura
    T. Shimoi
    M. Kodaira
    K. Yonemori
    C. Shimizu
    Y. Fujiwara
    T. Kato
    K. Tamura
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 1283 - 1288
  • [4] Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas
    Ebata, T.
    Yunokawa, M.
    Bun, S.
    Shimomura, A.
    Shimoi, T.
    Kodaira, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Kato, T.
    Tamura, K.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (06) : 1283 - 1288
  • [5] Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer
    Bun, Seiko
    Yunokawa, Mayu
    Ebata, Takahiro
    Shimomura, Akihiko
    Shimoi, Tatsunori
    Kodaira, Makoto
    Yonemori, Kan
    Shimizu, Chikako
    Fujiwara, Yasuhiro
    Kato, Tomoyasu
    Makino, Yoshinori
    Hayashi, Yoshikazu
    Tamura, Kenji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 745 - 752
  • [6] Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer
    Seiko Bun
    Mayu Yunokawa
    Takahiro Ebata
    Akihiko Shimomura
    Tatsunori Shimoi
    Makoto Kodaira
    Kan Yonemori
    Chikako Shimizu
    Yasuhiro Fujiwara
    Tomoyasu Kato
    Yoshinori Makino
    Yoshikazu Hayashi
    Kenji Tamura
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 745 - 752
  • [7] Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian, and primary peritoneal carcinomas
    Takahiro, E.
    Kodaira, M.
    Shimoi, T.
    Shimomura, A.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S547 - S547
  • [8] Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer
    Yoshihama, Tomoko
    Nomura, Hiroyuki
    Iwasa, Naomi
    Kataoka, Fumio
    Hashimoto, Shiho
    Nanki, Yoshiko
    Hirano, Takuro
    Makabe, Takeshi
    Sakai, Kensuke
    Yamagami, Wataru
    Hirasawa, Akira
    Aoki, Daisuke
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (11) : 1019 - 1023
  • [9] Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study
    Shibutani, Takashi
    Nagao, Shoji
    Suzuki, Kazuhiro
    Kaneda, Michiko
    Yamamoto, Kasumi
    Jimi, Tomoatsu
    Yano, Hiroko
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Sudo, Tamotsu
    Yamaguchi, Satoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (03) : 502 - 507
  • [10] Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study
    Takashi Shibutani
    Shoji Nagao
    Kazuhiro Suzuki
    Michiko Kaneda
    Kasumi Yamamoto
    Tomoatsu Jimi
    Hiroko Yano
    Miho Kitai
    Takaya Shiozaki
    Kazuko Matsuoka
    Tamotsu Sudo
    Satoshi Yamaguchi
    International Journal of Clinical Oncology, 2020, 25 : 502 - 507
12345